Concepedia

Nora Schenk

NS

3

Publications

521

Citations

3

H-Index

2008

Active since

Affiliations

Weston Park Cancer Centre(Current)

Novartis (United States)

Universitair Ziekenhuis Leuven

Nora Schenk is an author at Weston Park Cancer Centre.

Publications per year

2008–2011

3

Publications

3

Effective inhibition of aromatase inhibitor‐associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole

Nigel Bundred, Ian Campbell, Neville Davidson et al. · Cancer · 2008 · 216 citations

Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole

Adam Brufsky, Nigel Bundred, Robert E. Coleman et al. · The Oncologist · 2008 · 175 citations

Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial

Antonio Llombart‐Cussac, Antonio Frassoldati, Outi Paija et al. · Clinical Breast Cancer · 2011 · 130 citations · Full text

Rows per page

1–3 of 3